The tumor suppressor LKB1 induces p21 expression in collaboration with LMO4, GATA-6, and Ldb1

Biochemical and Biophysical Research Communications

Volumn 343, Issue 4, 2006, Pages 1186-1190

  Setogawa, Takeshi ^a   Shinozaki Yabana, Satoko ^a   Masuda, Takahisa ^a   Matsuura, Ken ^a   Akiyama, Tetsu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

GATA 6; Ldb1; LKB1; LMO4; p21; Peutz Jeghers syndrome; Tumor suppressor

Indexed keywords

PROTEIN; PROTEIN LDB1; PROTEIN LMO4; PROTEIN P21; TRANSCRIPTION FACTOR GATA 6; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN LKB1; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; GATA6 TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEINS; HUMANS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES; UP-REGULATION;

EID: 33646035501     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.03.077     Document Type: Article

References (30)

1. Peutz J.L. On a very remarkable case of familial polyposis of mucous membrane of intestinal tract and accompanied by peculiar pigmentations of skin and mucous membrane. Ned. Tijdschr. Geneeskd. 10 (1921) 134-146
2. Jeghers H., McKusick V., and Katz K. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. N. Engl. J. Med. 241 (1949) 992-1005
3. Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell. Mol. Life Sci. 55 (1999) 735-750
4. Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., Bignell G., Warren W., Aminoff M., Hoglund P., Jarvinen H., Kristo P., Pelin K., Ridanpaa M., Salovaara R., Toro T., Bodmer W., Olschwang S., Olsen A.S., Stratton M.R., de la Chapelle A., and Aaltonen L.A. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391 (1998) 184-187
5. Jenne D.E., Reimann H., Nezu J., Friedel W., Loff S., Jeschke R., Muller O., Back W., and Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 18 (1998) 38-43
6. Sanchez-Cespedes M., Parrella P., Esteller M., Nomoto S., Trink B., Engles J.M., Westra W.H., Herman J.G., and Sidransky D. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 62 (2002) 3659-3662
7. Marignani P.A., Kanai F., and Carpenter C.L. LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J. Biol. Chem. 276 (2001) 32415-32418
8. Sapkota G.P., Kieloch A., Lizcano J.M., Lain S., Arthur J.S., Williams M.R., Morrice N., Deak M., and Alessi D.R. Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90RSK and PKA but not its farnesylation at Cys433 are essential for LKB1 to suppress cell growth. J. Biol. Chem. 276 (2001) 19469-19482
9. Tiainen M., Vaahtomeri K., Ylikorkala A., and Makela T.P. Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1). Hum. Mol. Genet. 11 (2002) 1497-1504
10. Karuman P., Gozani O., Odze R.D., Zhou X.C., Zhu H., Shaw R., Brien T.P., Bozzuto C.D., Ooi D., Cantley L.C., and Yuan J. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol. Cell 7 (2001) 1307-1319
11. Smith D.P., Rayter S.I., Niederlander C., Spicer J., Jones C.M., and Ashworth A. LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1. Hum. Mol. Genet. 10 (2001) 2869-2877
12. Spicer J., Rayter S., Young N., Elliott R., Ashworth A., and Smith D. Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1. Oncogene 22 (2003) 4752-4756
13. Ossipova O., Bardeesy N., DePinho R.A., and Green J.B. LKB1 (XEEK1) regulates Wnt signalling in vertebrate development. Nat. Cell Biol. 5 (2003) 889-894
14. Lin-Marq N., Borel C., and Antonarakis S.E. Peutz-Jeghers LKB1 mutants fail to activate GSK-3b, preventing it from inhibiting Wnt signaling. Mol. Genet. Genomics 273 (2005) 184-196
15. Bardeesy N., Sinha M., Hezel A.F., Signoretti S., Hathaway N.A., Sharpless N.E., Loda M., Carrasco D.R., and DePinho R.A. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419 (2002) 162-167
16. Martin S.G., and St Johnston D. A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature 421 (2003) 379-384
17. Baas A.F., Kuipers J., van der Wel N.N., Batlle E., Koerten H.K., Peters P.J., and Clevers H.C. Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 116 (2004) 457-466
18. Hardie D.G. New roles for the LKB1-AMPK pathway. Curr. Opin. Cell Biol. 17 (2005) 167-173
19. Adachi S., Jigami T., Yasui T., Nakano T., Ohwada S., Omori Y., Sugano S., Ohkawara B., Shibuya H., Nakamura T., and Akiyama T. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling. Cancer Res. 64 (2004) 8496-8501
20. Ho C.K., and Strauss III J.F. Activation of the control reporter plasmids pRL-TK and pRL-SV40 by multiple GATA transcription factors can lead to aberrant normalization of transfection efficiency. BMC Biotechnol. 4 (2004) 10
21. Sugihara T.M., Bach I., Kioussi C., Rosenfeld M.G., and Andersen B. Mouse deformed epidermal autoregulatory factor 1 recruits a LIM domain factor, LMO-4, and CLIM coregulators. Proc. Natl. Acad. Sci. USA 95 (1998) 15418-15423
22. Peterkin T., Gibson A., Loose M., and Patient R. The roles of GATA-4, -5 and -6 in vertebrate heart development. Semin. Cell Dev. Biol. 16 (2005) 83-94
23. Ono Y., Fukuhara N., and Yoshie O. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol. Cell. Biol. 18 (1998) 6939-6950
24. Mehenni H., Gehrig C., Nezu J., Oku A., Shimane M., Rossier C., Guex N., Blouin J.L., Scott H.S., and Antonarakis S.E. Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity. Am. J. Hum. Genet. 63 (1998) 1641-1650
25. Ylikorkala A., Avizienyte E., Tomlinson I.P., Tiainen M., Roth S., Loukola A., Hemminki A., Johansson M., Sistonen P., Markie D., Neale K., Phillips R., Zauber P., Twama T., Sampson J., Jarvinen H., Makela T.P., and Aaltonen L.A. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum. Mol. Genet. 8 (1999) 45-51
26. Perlman H., Suzuki E., Simonson M., Smith R.C., and Walsh K. GATA-6 induces p21(Cip1) expression and G1 cell cycle arrest. J. Biol. Chem. 273 (1998) 13713-13718
27. Nagata D., Suzuki E., Nishimatsu H., Yoshizumi M., Mano T., Walsh K., Sata M., Kakoki M., Goto A., Omata M., and Hirata Y. Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells. Circ. Res. 87 (2000) 699-704
28. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 (1990) 1129-1136
29. Gao X., Sedgwick T., Shi Y.B., and Evans T. Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors in the regulation of intestine epithelial cell differentiation. Mol. Cell. Biol. 18 (1998) 2901-2911
30. Oesterreicher T.J., and Henning S.J. Rapid induction of GATA transcription factors in developing mouse intestine following glucocorticoid administration. Am. J. Physiol. Gastrointest. Liver Physiol. 286 (2004) G947-G953